ENTtoday
  • Home
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Multimedia
    • Video
    • Audio
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
    • eNewsletters
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Injection to Treat Double Chin Hits Market

by Thomas R. Collins • September 8, 2015

  • Tweet
  • Email
Print-Friendly Version

A total of 1,022 patients participated in the trials—514 received ATX-101 and 508 received a placebo. More than 68% of patients reported at least a one-point improvement on a composite of the clinician- and patient-reported Submental Fat Rating Scale, which uses a 0 through 4 scale. That compared with 20.5% in the placebo group (P<.001). Sixteen percent of the treatment group reported an improvement of two points or more, compared with 1.5% in the placebo group (P<.001).

You might also like:

  • Chin Augmentation on the Rise
  • Drug-Eluting Sinus Stent Hits the Market: May help maintain patency after FESS
  • In-Office Injection Laryngoplasty: Good Results, but Complications More Likely
  • Double Benefit? The case for bilateral cochlear implants
Explore this issue:
September 2015
One could say, wouldn’t you be better with liposuction? The answer is, there are a lot of people who just don’t want surgery. They want something nonsurgical.—Ed Williams, MD

The most common adverse events were pain, swelling, bruising, and numbness, but most were transient and expected due to the nature of the treatment,

researchers reported. In the trials, 4% of patients had facial nerve injury that caused an uneven smile or muscle weakness, but those symptoms resolved.

Kythera, which is expected to be bought by Allergan in a $2.1 billion deal, says the injections should be used with caution in patients with bleeding abnormalities and in those who are on anticoagulants (The Wall Street Journal, August 5, 2015). The company also cautions that it should not be injected into or in close proximity to the marginal mandibular branch of the facial nerve.

Ed Williams, MD, founding physician at the Williams Center Plastic Surgery Specialists in Albany, N.Y., and the president-elect of the American Academy of Facial Plastic and Reconstructive Surgery, said he was initially “very skeptical” of Kybella. But after speaking with the company’s founder and becoming a paid trainer, he now thinks the treatment has a place in the field. He has treated approximately 25 patients and, using a topical anesthetic and lidocaine and a thin, 30-gauge needle, has been able to make the procedure pain-free, he said.

“One could say, wouldn’t you be better with liposuction?” he said. “And the answer is, there are a lot of people who just don’t want surgery. They want something nonsurgical.”

He acknowledged that the treatment is “not inexpensive” and that with multiple injections the cost can add up quickly. But some patients will still prefer the procedure over liposuction, he said. “I learned years ago not to get into consumers’ heads, because just when you think you’ve got it figured out, something different happens,” he added.

Pages: 1 2 3 4 Single Page

Filed Under: Facial Plastic/Reconstructive, Features, Practice Focus Tagged With: double chin, injection, Kybella, submental fullnessIssue: September 2015

You might also like:

  • Chin Augmentation on the Rise
  • Drug-Eluting Sinus Stent Hits the Market: May help maintain patency after FESS
  • In-Office Injection Laryngoplasty: Good Results, but Complications More Likely
  • Double Benefit? The case for bilateral cochlear implants

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • How Physicians Can Build a Network to Boost Their Career
  • How To Survive the First Year of Medical Residency
  • ACGME Revises Cap on Resident Work Hours
  • Ethical Implications of Burnout in Otolaryngology Residents
  • How Physicians Can Plan for Maternity Leave
  • Popular this Week
  • Most Popular
  • Most Recent
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Vertigo in the Elderly: What Does It Mean?
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Complications for When Physicians Change a Maiden Name
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • Vertigo in the Elderly: What Does It Mean?
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Post-Operative Pain in Children Undergoing Tonsillectomy
    • Otolaryngology’s #MeToo: Gender Bias and Sexual Harassment in Medicine
    • Women in Otolaryngology: Do we belong here?
    • Letter from the Editor: We All Need to Take #MeToo Personally
    • What Otolaryngologists Should Consider When Prescribing Opioids
    • What Additional Treatment Is Indicated for Oral Cavity Cancer with Isolated Perineural Invasion?

Polls

Have you experienced or witnessed sexual discrimination or harassment in your workplace?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy

Visit: The Triological Society • The Laryngoscope • Triological Meeting Posters

Wiley
© 2018 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.